Furthermore, the IL-6 and CRP contents in the three PSP treatment groups varied inversely with the PSP dose from low to high, and no significant difference in the IL-6 and CRP levels was found between the PSP-H group and the NC group. Here, CRP is linked to supranuclear palsy, progressive, 1.